Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Allergy and Asthma Reports
Published in: Current Allergy and Asthma Reports 4/2016

01-04-2016 | Rhinitis (JJ Oppenheimer and J Corren, Section Editors)

Diagnosis and Management of Rhinosinusitis: Highlights from the 2015 Practice Parameter

Authors: Kathleen Dass, Anju Tripathi Peters

Published in: Current Allergy and Asthma Reports | Issue 4/2016

Login to get access

Abstract

Rhinosinusitis is a commonly diagnosed disease in the USA. Rhinosinusitis is classified as acute, recurrent, or chronic (with or without nasal polyps). While acute rhinosinusitis is diagnosed by history and physical examination, chronic rhinosinusitis and recurrent acute rhinosinusitis are diagnosed based on symptoms and the presence of disease on either a sinus CT scan and/or endoscopy. Management of uncomplicated acute rhinosinusitis includes analgesics, saline irrigation, and/or intranasal steroids. Antibiotics and intranasal steroids are recommended for acute bacterial rhinosinusitis. Intranasal and oral steroids with antibiotics are recommended to treat chronic rhinosinusitis although the evidence for antibiotics is weak. Biologics such as omalizumab and mepolizumab are being investigated for the treatment of chronic rhinosinusitis with nasal polyps. Surgery may be indicated in management of refractory chronic rhinosinusitis and rarely for acute bacterial rhinosinusitis. This review discusses highlights of the updated 2014 practice parameter and up-to-date evidence from other literature sources.
Literature
1.
Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. adults: national health interview survey, 2012. Vital Health Stat. 2014;10:1–171.
2.••
Peters AT et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014;113(4):347–85. Up-to-date practice parameter highlighting new evidence and information regarding the pathogenesis, diagnosis, and management of acute and chronic rhinosinusitis.CrossRefPubMed
3.
Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg. 1997;117:S1eS7. IV.CrossRef
4.
Kaliner MA, Osguthorpe JD, Fireman P, et al. Sinusitis: bench to bedside. Current findings, future directions. Otolaryngol Head Neck Surg. 1997;116:S1eS20.CrossRef
5.
Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114(suppl):155e212.
6.
Gwaltney Jr JM, Scheld WM, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol. 1992;90:457e461. discussion 62.
7.
Tan B, Schleimer RP, Kern RC. Perspectives on the etiology of chronic rhinosinusitis. Curr Open Otolaryngol Head Neck Surg. 2010;18(1):21–6.CrossRef
8.
Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114:S155–212.CrossRef
9.••
Stevens W et al. Cytokines in chronic rhinosinusitis role in eosinophilia and aspirin-exacerbated respiratory disease. Am J Respir Crit Care Med. 2015;192(6):682–94. Demonstration that chronic rhinosinusitis is not Th1 driven and lacks elevation of IFN gamma.CrossRefPubMed
10.
Gwaltney Jr JM. Acute community-acquired sinusitis. Clin Infect Dis. 1996;23:1209e1223. quiz 24e25. IV.CrossRef
11.
Lund VJ, Kennedy DW. Quantification for staging sinusitis. The staging and therapy group. Ann Otol Rhinol Laryngol Suppl. 1995;167:17e21.
12.
Mafee MF, Tran BH, Chapa AR. Imaging of rhinosinusitis and its complications: plain film, CT, and MRI. Clin Rev Allergy Immunol. 2006;30:165e186.CrossRef
13.
Rachelefsky GS, Katz RM, Siegel SC. Chronic sinusitis in children with respiratory allergy: the role of antimicrobials. J Allergy Clin Immunol. 1982;69:382e387.
14.
Savolainen S. Allergy in patients with acute maxillary sinusitis. Allergy. 1989;44:116e122.CrossRef
15.
Van Dishoeck HA, Franssen MG. The incidence and correlation of allergy and chronic maxillary sinusitis. Pract Otorhinolaryngol (Basel). 1957;19:502e506.
16.
Emanuel IA, Shah SB. Chronic rhinosinusitis: allergy and sinus computed tomography relationships. Otolaryngol Head Neck Surg. 2000;123:687e691.CrossRef
17.
Gosepath J, Pogodsky T, Mann WJ. Characteristics of recurrent chronic rhinosinusitis after previous surgical therapy. Acta Otolaryngol. 2008;128:778e784.
18.
Van Lancker JA, Yarnold PA, Ditto AM, et al. Aeroallergen hypersensitivity: comparing patients with nasal polyps to those with allergic rhinitis. Allergy Asthma Proc. 2005;26:109e112.
19.•
DeYoung K, Wentzel JL, Schlosser RJ, et al. Systematic review of immunotherapy for chronic rhinosinusitis. Am J Rhinol Allergy. 2014;28(2):145–50. Up-to-date review of immunotherapy for chronic rhinosinusitis patients.CrossRefPubMed
20.
Slavin RJ et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol. 2005;116(6 Suppl):S13–47.CrossRefPubMed
21.
Flook EP, Kumar BN. Is there evidence to link acid reflux with chronic sinusitis or any nasal symptoms? A review of the evidence. Rhinology. 2011;49:11e16.
22.••
Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012;(23). 3 p preceding table of contents, 1e298. Important international effort defining and classifying rhinosinusitis, which also highlights antibiotic options.
23.••
Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012;54:e72ee112. Important national effort that provides antibiotic recommendations for acute bacterial rhinosinusitis.CrossRef
24.
Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol. 2005;116:1289e1295.CrossRef
25.•
Keith PK, Dymek A, Pfaar O, et al. Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo controlled study. Prim Care Respir J. 2012;21:267e275. Demonstration that intranasal steroid as monotherapy caused improvement in acute bacterial rhinosinusitis symptoms.
26.
Bachert C, Meltzer EO. Effect of mometasone furoate nasal spray on quality of life of patients with acute rhinosinusitis. Rhinology. 2007;45:190e196.
27.
Zalmanovici A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. 2009;4:CD005149. Ia.
28.•
Venekamp RP, Bonten MJ, Rovers MM, Verheij TJ, Sachs AP. Systemic corticosteroid monotherapy for clinically diagnosed acute rhinosinusitis: a randomized controlled trial. CMAJ. 2012;184:E751eE757. Demonstration that systemic monotherapy is not superior to placebo in acute bacterial rhinosinusitis.CrossRef
29.
Venekamp RP, Thompson MJ, Hayward G, et al. Systemic corticosteroids for acute sinusitis. Cochrane Database Syst Rev. 2011;12:CD008115.PubMed
30.
Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev. 2011;2:CD001364.PubMed
31.
Williamson IG, Rumsby K, Benge S, et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA. 2007;298:2487e2496.CrossRef
32.
Wu T, Zhang J, Qiu Y, Xie L, Liu GJ. Chinese medicinal herbs for the common cold. Cochrane Database Syst Rev. 2007;1:CD004782.PubMed
33.
Kassel JC, King D, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev. 2010;3:CD006821.PubMed
34.
Hamilos DL. Chronic rhinosinusitis: epidemiology and medical management. J Allergy Clin Immunol. 2011;128:693e707; quiz 8e9.
35.
Scheinberg PA, Otsuji A. Nebulized antibiotics for the treatment of acute exacerbations of chronic rhinosinusitis. Ear Nose Throat J. 2002;81:648e652.
36.
Vaughan WC, Carvalho G. Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolaryngol Head Neck Surg. 2002;127:558e568.CrossRef
37.
Uren B, Psaltis A, Wormald PJ. Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis. Laryngoscope. 2008;118:1677e1680.CrossRef
38.
Elliott KA, Stringer SP. Evidence-based recommendations for antimicrobial nasal washes in chronic rhinosinusitis. Am J Rhinol. 2006;20:1e6.
39.
Whatley WS, Chandra RK, MacDonald CB. Systemic absorption of gentamicin nasal irrigations. Am J Rhinol. 2006;20:1–6.CrossRef
40.
Cheng AG, Johnston PR, Luz J, et al. Sensorineural hearing loss in patients with cystic fibrosis. Otolaryngol Head Neck Surg. 2009;141:86–90.CrossRefPubMed
41.
Wei JL, Sykes KJ, Johnson P, He J, Mayo MS. Safety and efficacy of once-daily nasal irrigation for the treatment of pediatric chronic rhinosinusitis. Laryngoscope. 2011;121:1989e2000.
42.
Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. 2007;3:CD006394.PubMed
43.
Pynnonen MA, Mukerji SS, Kim HM, Adams ME, Terrell JE. Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. Arch Otolaryngol Head Neck Surg. 2007;133:1115e1120.CrossRef
44.
Keen M, Foreman A, Wormald PJ. The clinical significance of nasal irrigation bottle contamination. Laryngoscope. 2010;120:2110e2114.CrossRef
45.
Piromchai P, Thanaviratananich S, Laopaiboon M. Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults. Cochrane Database Syst Rev. 2011;5:CD008233.PubMed
46.
Dubin MG, Kuhn FA, Melroy CT. Radiographic resolution of chronic rhinosinusitis without polyposis after 6 weeks vs 3 weeks of oral antibiotics. Ann Allergy Asthma Immunol. 2007;98:32e35.CrossRef
47.•
Sreenath SB, Taylor RJ, Miller JD, et al. A prospective randomized cohort study evaluating 3 weeks vs 6 weeks of oral antibiotic treatment in the setting of “maximal medical therapy” for chronic rhinosinusitis. Int Forum Allergy Rhinol. 2015;5(9):820–8. Demonstration that there is no difference in clinical outcomes between 3- and 6- week courses of antibiotics in chronic rhinosinusitis patients.CrossRefPubMed
48.
Schalek P, Petras P, Klement V, Hahn A. Short-term antibiotics treatment in patients with nasal polyps and enterotoxins producing Staphylococcus aureus strains. Eur Arch Otorhinolaryngol. 2009;266:1909e1913.CrossRef
49.
Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125:1069e1076e4.
50.
Ozturk F, Bakirtas A, Ileri F, Turktas I. Efficacy and tolerability of systemic methylprednisolone in children and adolescents with chronic rhinosinusitis: a double-blind, placebo-controlled randomized trial. J Allergy Clin Immunol. 2011;128:348e352.CrossRef
51.
Alobid I, Benitez P, Pujols L, et al. Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long term intranasal steroid treatment. Rhinology. 2006;44:8e13.
52.
Hissaria P, Smith W, Wormald PJ, et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol. 2006;118:128e133.CrossRef
53.
Small CB, Stryszak P, Danzig M, Damiano A. Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis. J Allergy Clin Immunol. 2008;121:928–32.CrossRefPubMed
54.
Snidvongs K, Kalish L, Sacks R, Craig JC, Harvey RJ. Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database Syst Rev. 2011;8:CD009274.PubMed
55.
Pinto JM, Mehta N, DiTineo M, Wang J, Baroody FM, Naclerio RM. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010;48:318e324.
56.••
Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2013;131:110e116.e1. Demonstration that omalizumab significantly decreased total nasal endoscopic polyp scores.CrossRef
57.
Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized antieIL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;128:989e995.e1e8.CrossRef
58.
Gevaert P, Lang-Loidolt D, Lackner A, et al. Nasal IL-5 levels determine the response to antieIL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol. 2006;118:1133e1141.CrossRef
59.
Ebbens FA, Scadding GK, Badia L, et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2006;118:1149e1156.CrossRef
60.
Kennedy DW, Kuhn FA, Hamilos DL, et al. Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. Laryngoscope. 2005;115:1793e1799.CrossRef
61.
Plaza G, Eisenberg G, Montojo J, Onrubia T, Urbasos M, O’Connor C. Balloon dilation of the frontal recess: a randomized clinical trial. Ann Otol Rhinol Laryngol. 2011;120:511e518.CrossRef
62.•
Tomazic PV, Stammberger H, Braun H, et al. Feasibility of balloon sinuplasty in patients with chronic rhinosinusitis: the Graz experience. Rhinology. 2013;51:120e127. Demonstration that balloon sinuplasty is not comparable to traditional functional endoscopic sinus surgery.
63.•
Koskinen A, Penttila M, Myller J, et al. Endoscopic sinus surgery might reduce exacerbations and symptoms more than balloon sinuplasty. Am J Rhinol Allergy. 2012;26:e150ee156. Demonstration that functional endoscopic sinus surgery might reduce exacerbations more so than balloon sinuplasty in patients with chronic rhinosinusitis.CrossRef
64.
Khalil HS, Nunez DA. Functional endoscopic sinus surgery for chronic rhinosinusitis. Cochrane Database Syst Rev. 2006;3:CD004458.PubMed
65.
Rimmer J, Fokkens W, Chong LY, Hopkins C. Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps. Cochrane Database Syst Rev. 2014;12:CD006991.PubMed
66.•
Han JK, Marple BF, Smith TL, et al. Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: an efficacy metaanalysis. Int Forum Allergy Rhinol. 2012;2:271e279. Demonstration that steroid-releasing stents decrease post -operative oral steroid requirements.CrossRef
67.•
Marple BF, Smith TL, Han JK, et al. Advance II: a prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants. Otolaryngol Head Neck Surg. 2012;146:1004e1011. Demonstration that steroid-releasing stents leads to improved surgical outcomes in patients with chronic rhinosinusitis.CrossRef
68.
Forwith KD, Chandra RK, Yun PT, Miller SK, Jampel HD. ADVANCE: a multisite trial of bioabsorbable steroid-eluting sinus implants. Laryngoscope. 2011;121:2473e2480.CrossRef
Metadata
Title
Diagnosis and Management of Rhinosinusitis: Highlights from the 2015 Practice Parameter
Authors
Kathleen Dass
Anju Tripathi Peters
Publication date
01-04-2016
Publisher
Springer US
Published in
Current Allergy and Asthma Reports / Issue 4/2016
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-016-0607-8

Other articles of this Issue 4/2016

Current Allergy and Asthma Reports 4/2016 Go to the issue

Immunotherapy and Immunomodulators (B Vickery, Section Editor)

Baked Egg and Milk Exposure as Immunotherapy in Food Allergy

Immunologic/Diagnostic Tests in Allergy (M Chapman and A Pomés, Section Editors)

Pollen Allergens for Molecular Diagnosis

Allergens (RK Bush and JA Woodfolk, Section Editors)

Asthma in Urban Children: Epidemiology, Environmental Risk Factors, and the Public Health Domain

Immunotherapy and Immunomodulators (B Vickery, Section Editor)

The Heterogeneity of Oral Immunotherapy Clinical Trials: Implications and Future Directions

Allergic Skin Diseases (L Fonacier, Section Editor)

Mucosal Lesions in an Allergy Practice

Allergens (RK Bush and JA Woodfolk, Section Editors)

Rhinoviruses and Their Receptors: Implications for Allergic Disease